All 157 XBI (STATE STREET(R) SPDR(R) S&P(R) BIOTECH ETF) Holdings
There are 157 XBI holdings. Top 10 companies weight: 13.61%.
Total Market Cap: $1.70T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (157 stocks) | +9.95% | 31.39 | 16.62 | 0.44 | +21.40% | +14.06% | 0.66 | ||||||||||
1 | APGE | Apogee Therapeutics Inc | 1.55% | $134.15 | $10B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 69 | -2.70% | $131 | 0.00% | 1.25 |
2 | ERAS | Erasca Inc | 1.52% | $18.82 | $5.51B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +21.15% | $23 | -1.13% | 1.37 |
3 | MRNA | Moderna Inc | 1.42% | $59.49 | $27B | Biotechnology | Healthcare | N/A | N/A | 23.04 | N/A | N/A | N/A | 46 | -18.88% | $48 | -28.62% | 1.37 |
4 | KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.39% | $111.06 | $9.38B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +12.68% | $125 | +14.19% | 1.52 |
5 | TWST | Twist Bioscience Corp | 1.31% | $87.45 | $5.76B | Diagnostics & Research | Healthcare | -10.29% | N/A | N/A | N/A | N/A | N/A | 77 | +1.20% | $89 | -6.60% | 2.02 |
6 | VKTX | Viking Therapeutics Inc | 1.30% | $36.38 | $4.38B | Biotechnology | Healthcare | +47.58% | N/A | N/A | N/A | N/A | N/A | 78 | +154.48% | $93 | +43.88% | 1.52 |
7 | SYRE | Spyre Therapeutics Inc | 1.30% | $97.33 | $8.05B | Biotechnology | Healthcare | -2.15% | N/A | N/A | N/A | N/A | N/A | 75 | +6.78% | $104 | -10.71% | 1.74 |
8 | ORKA | Oruka Therapeutics Inc | 1.29% | $91.71 | $4.35B | Biotechnology | Healthcare | +11.91% | N/A | N/A | N/A | N/A | N/A | 78 | +57.75% | $145 | +31.48% | N/A |
9 | CGON | Cg Oncology Inc | 1.27% | $70.19 | $6.42B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +28.64% | $90 | 0.00% | 1.46 |
10 | PRAX | N/A | 1.26% | $304.43 | $8.87B | Biotechnology | Healthcare | -18.18% | N/A | N/A | N/A | N/A | N/A | 75 | +100.39% | $610 | +3.11% | 0.93 |
11 | DNTH | Dianthus Therapeutics Inc | 1.25% | $101 | $5.45B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +27.31% | $129 | 0.00% | 1.11 |
12 | MIRM | Mirum Pharmaceuticals Inc | 1.23% | $116.62 | $7.37B | Biotechnology | Healthcare | -34.51% | N/A | 2000.00 | N/A | N/A | N/A | 82 | +25.62% | $147 | +48.33% | 0.84 |
13 | RVMD | Revolution Medicines Inc Ordinary Shares | 1.22% | $180.39 | $37B | Biotechnology | Healthcare | +30.12% | N/A | N/A | N/A | N/A | N/A | 78 | +11.15% | $201 | +42.94% | 1.09 |
14 | NTRA | Natera Inc | 1.22% | $262.63 | $40B | Diagnostics & Research | Healthcare | -11.74% | N/A | N/A | N/A | N/A | N/A | 77 | +7.43% | $282 | +17.53% | 1.29 |
15 | RYTM | Rhythm Pharmaceuticals Inc | 1.22% | $104.60 | $7.51B | Biotechnology | Healthcare | +17.00% | N/A | N/A | N/A | N/A | N/A | 79 | +33.59% | $140 | +39.42% | 0.88 |
16 | PTGX | Protagonist Therapeutics Inc | 1.22% | $134.27 | $8.70B | Biotechnology | Healthcare | +1.43% | N/A | 29.85 | N/A | N/A | N/A | 78 | -6.79% | $125 | +22.86% | 0.21 |
17 | COGT | Cogent Biosciences Inc | 1.20% | $38.30 | $6.71B | Biotechnology | Healthcare | -15.32% | N/A | N/A | N/A | N/A | N/A | 75 | +41.64% | $54 | +40.97% | 1.71 |
18 | PCVX | Vaxcyte Inc Ordinary Shares | 1.19% | $55.50 | $8.19B | Biotechnology | Healthcare | +33.90% | N/A | N/A | N/A | N/A | N/A | 75 | +96.40% | $109 | +18.66% | 0.73 |
19 | RLAY | Relay Therapeutics Inc Ordinary Shares | 1.18% | $19.18 | $3.69B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +32.33% | $25 | -11.08% | 1.84 |
20 | CYTK | Cytokinetics Inc | 1.18% | $79.11 | $10B | Biotechnology | Healthcare | +27.73% | N/A | 117.65 | N/A | N/A | N/A | 80 | +36.27% | $108 | +21.99% | 0.77 |
21 | BBIO | Bridgebio Pharma Inc | 1.17% | $80.76 | $16B | Biotechnology | Healthcare | -3.14% | N/A | N/A | N/A | N/A | N/A | 79 | +29.74% | $105 | +5.57% | 1.02 |
22 | ROIV | Roivant Sciences Ltd Ordinary Shares | 1.17% | $34.05 | $25B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +15.48% | $39 | 0.00% | 0.90 |
23 | SRRK | Scholar Rock Holding Corp | 1.17% | $50.66 | $6.44B | Biotechnology | Healthcare | +5.29% | N/A | N/A | N/A | N/A | N/A | 79 | +17.07% | $59 | +9.02% | 0.67 |
24 | TVTX | Travere Therapeutics Inc Ordinary Shares | 1.16% | $55.47 | $5.24B | Biotechnology | Healthcare | -44.12% | N/A | 77.52 | N/A | N/A | N/A | 76 | +5.21% | $58 | +32.19% | 1.28 |
25 | TGTX | Tg Therapeutics Inc | 1.16% | $53.96 | $8.64B | Biotechnology | Healthcare | N/A | 18.97 | 58.48 | 0.02 | N/A | N/A | 66 | +8.19% | $58 | +7.20% | 0.80 |
26 | INSM | Insmed Inc | 1.14% | $107.02 | $24B | Biotechnology | Healthcare | +12.24% | N/A | 16.37 | 1.09 | N/A | N/A | 80 | +83.50% | $196 | +32.69% | 0.77 |
27 | ALKS | Alkermes Plc | 1.13% | $51.72 | $8.65B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 56.04 | 136.99 | 1.96 | N/A | N/A | N/A | N/A | N/A | +16.50% | N/A |
28 | RARE | Ultragenyx Pharmaceutical Inc | 1.12% | $28.53 | $3.12B | Biotechnology | Healthcare | +15.22% | N/A | N/A | N/A | N/A | N/A | 78 | +84.12% | $53 | -19.60% | 0.97 |
29 | MDGL | Madrigal Pharmaceuticals Inc | 1.12% | $535.69 | $13B | Biotechnology | Healthcare | +23.26% | N/A | 666.67 | N/A | N/A | N/A | 76 | +26.73% | $679 | +41.75% | 0.76 |
30 | SMMT | Summit Therapeutics Inc Ordinary Shares | 1.08% | $13.50 | $12B | Biotechnology | Healthcare | N/A | N/A | 3.72 | N/A | N/A | N/A | 60 | +113.33% | $29 | +12.03% | 1.75 |
31 | VERA | Vera Therapeutics Inc Class A | 1.08% | $36.99 | $3.04B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +121.11% | $82 | +17.52% | 1.22 |
32 | KRYS | Krystal Biotech Inc | 1.07% | $339.22 | $10B | Biotechnology | Healthcare | N/A | 45.34 | 46.95 | 0.57 | N/A | N/A | 72 | +6.62% | $362 | +39.91% | 0.92 |
33 | SLS | Sellas Life Sciences Group Inc | 1.06% | $12.48 | $2.32B | Biotechnology | Healthcare | -32.56% | N/A | N/A | N/A | N/A | N/A | 87 | +120.44% | $28 | +6.05% | 0.90 |
34 | REGN | Regeneron Pharmaceuticals Inc | 1.06% | $672.15 | $69B | Biotechnology | Healthcare | +20.31% | 15.86 | 15.08 | 88.04 | N/A | N/A | 72 | +21.87% | $819 | +3.03% | 0.60 |
35 | VRTX | Vertex Pharmaceuticals Inc | 1.05% | $480.50 | $121B | Biotechnology | Healthcare | +9.89% | 27.99 | 25.45 | 1.72 | N/A | N/A | 72 | +15.39% | $554 | +19.61% | 0.49 |
36 | INCY | Incyte Corp | 1.04% | $115.65 | $23B | Biotechnology | Healthcare | +27.16% | 15.82 | 15.06 | N/A | N/A | N/A | 61 | -1.58% | $114 | +7.88% | 0.57 |
37 | GILD | Gilead Sciences Inc | 1.04% | $133.21 | $164B | Drug Manufacturers - General | Healthcare | +98.59% | 17.75 | 15.22 | 0.32 | N/A | N/A | 74 | +18.83% | $158 | +18.49% | 0.35 |
38 | ABBV | Abbvie Inc | 1.04% | $253.44 | $432B | Drug Manufacturers - General | Healthcare | -19.65% | 139.08 | 18.02 | 0.40 | N/A | N/A | 74 | +5.18% | $267 | +21.10% | 0.28 |
39 | PTCT | Ptc Therapeutics Inc | 1.03% | $78.01 | $6.53B | Biotechnology | Healthcare | -16.59% | N/A | 56.82 | 0.81 | N/A | N/A | 75 | +22.97% | $96 | +12.92% | 0.99 |
40 | HALO | Halozyme Therapeutics Inc | 1.03% | $77.09 | $8.99B | Biotechnology | Healthcare | +20.06% | 25.62 | 10.78 | N/A | N/A | N/A | 67 | +8.83% | $84 | +12.87% | 0.62 |
41 | NBIX | Neurocrine Biosciences Inc | 1.02% | $173 | $17B | Drug Manufacturers - Specialty & Generic | Healthcare | +9.25% | 25.72 | 24.10 | 0.21 | N/A | N/A | 75 | +15.75% | $200 | +12.11% | 0.79 |
42 | GRAL | Grail Inc | 1.02% | $68.91 | $3.06B | Diagnostics & Research | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 61 | +1.76% | $70 | 0.00% | 2.22 |
43 | AMGN | Amgen Inc | 1.01% | $364.17 | $193B | Drug Manufacturers - General | Healthcare | +3.49% | 24.75 | 16.47 | 0.79 | N/A | N/A | 60 | -2.07% | $357 | +11.73% | 0.46 |
44 | EXEL | Exelixis Inc | 1.01% | $55.53 | $14B | Biotechnology | Healthcare | +72.24% | 17.54 | 17.70 | 0.45 | N/A | N/A | 59 | -8.28% | $51 | +26.67% | 0.52 |
45 | BEAM | Beam Therapeutics Inc | 1.00% | $26.33 | $3.17B | Biotechnology | Healthcare | -36.45% | N/A | N/A | N/A | N/A | N/A | 73 | +98.67% | $52 | -23.20% | 1.82 |
46 | BMRN | Biomarin Pharmaceutical Inc | 1.00% | $59.11 | $11B | Biotechnology | Healthcare | -20.33% | 42.21 | 11.96 | 0.73 | N/A | N/A | 75 | +48.81% | $88 | -5.79% | 0.65 |
47 | CRSP | Crispr Therapeutics Ag | 0.99% | $46.99 | $4.95B | Biotechnology | Healthcare | +2.10% | N/A | 23.36 | N/A | N/A | N/A | 70 | +83.46% | $86 | -18.22% | 1.44 |
48 | CELC | Celcuity Inc | 0.99% | $87.99 | $4.42B | Biotechnology | Healthcare | +36.83% | N/A | N/A | N/A | N/A | N/A | 79 | +85.76% | $163 | +32.62% | 1.07 |
49 | IMVT | Immunovant Inc | 0.99% | $39.92 | $8.13B | Biotechnology | Healthcare | +18.52% | N/A | N/A | N/A | N/A | N/A | 70 | +18.21% | $47 | +31.90% | 1.21 |
50 | ACAD | Acadia Pharmaceuticals Inc | 0.99% | $25.09 | $4.43B | Biotechnology | Healthcare | N/A | 11.73 | 76.34 | 0.19 | N/A | N/A | 72 | +30.13% | $33 | +1.12% | 0.90 |
XBI (STATE STREET(R) SPDR(R) S&P(R) BIOTECH ETF) Sector Allocation
HEALTHCARE
96.60%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%